Center-Authored Papers

Filters: Author is Bartenstein, Matthias  [Clear All Filters]
2017
Bhagat T, Chen S, Bartenstein M, Barlowe TS, von Ahrens D, Choudhary GS, Tivnan P, Amin E, Marcondes AM, Sanders MA et al..  2017.  Wnt/ß-catenin activation by epigenetically aberrant stroma drives myelodysplastic syndrome.. Cancer research. Abstract
2012
Deeg HJ, Bartenstein M.  2012.  Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: current status.. Archivum immunologiae et therapiae experimentalis. 60(1):31-41. Abstract
2011
Marcondes AM, Li X, Tabellini L, Bartenstein M, Kabacka J, Sale GE, Hansen JA, Dinarello CA, Deeg HJ.  2011.  Inhibition of IL-32 activation by {alpha}-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.. Blood. 118(18):5031-5037. Abstract
2010
Bartenstein M, Deeg HJ.  2010.  Hematopoietic stem cell transplantation for MDS.. Hematology/oncology clinics of North America. 24(2):407-22. Abstract